Breaking Barriers With Basal Insulin Biosimilars in Type 2 Diabetes

Detalhes bibliográficos
Autor(a) principal: Heller, Simon
Data de Publicação: 2023
Outros Autores: Raposo, João Filipe, Tofé, Santiago, Hanif, Wasim, Schroner, Zbynek, Down, Su, Blevins, Thomas
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10362/155497
Resumo: Funding Information: Financial support for this article was provided by Viatris, Inc. Publisher Copyright: ©2023 by the American Diabetes Association.
id RCAP_112d1172dd60b73660d0dcd5dc488184
oai_identifier_str oai:run.unl.pt:10362/155497
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Breaking Barriers With Basal Insulin Biosimilars in Type 2 DiabetesInternal MedicineEndocrinology, Diabetes and MetabolismSDG 3 - Good Health and Well-beingFunding Information: Financial support for this article was provided by Viatris, Inc. Publisher Copyright: ©2023 by the American Diabetes Association.Despite increases in the availability and effectiveness of other therapies, insulin remains an essential treatment for approximately 30 million people with type 2 diabetes worldwide. The development of biosimilars has created the potential for significant health care cost savings and may lead to greater access to basal insulin for vast populations. In this review, we discuss evidence demonstrating equipoise between basal insulin biosimilars and the patented analogs they may replace.NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)RUNHeller, SimonRaposo, João FilipeTofé, SantiagoHanif, WasimSchroner, ZbynekDown, SuBlevins, Thomas2023-07-18T22:16:23Z2023-032023-03-01T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/article9application/pdfhttp://hdl.handle.net/10362/155497eng0891-8929PURE: 66657222https://doi.org/10.2337/cd22-0016info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-03-11T05:38:05Zoai:run.unl.pt:10362/155497Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-20T03:56:05.981444Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Breaking Barriers With Basal Insulin Biosimilars in Type 2 Diabetes
title Breaking Barriers With Basal Insulin Biosimilars in Type 2 Diabetes
spellingShingle Breaking Barriers With Basal Insulin Biosimilars in Type 2 Diabetes
Heller, Simon
Internal Medicine
Endocrinology, Diabetes and Metabolism
SDG 3 - Good Health and Well-being
title_short Breaking Barriers With Basal Insulin Biosimilars in Type 2 Diabetes
title_full Breaking Barriers With Basal Insulin Biosimilars in Type 2 Diabetes
title_fullStr Breaking Barriers With Basal Insulin Biosimilars in Type 2 Diabetes
title_full_unstemmed Breaking Barriers With Basal Insulin Biosimilars in Type 2 Diabetes
title_sort Breaking Barriers With Basal Insulin Biosimilars in Type 2 Diabetes
author Heller, Simon
author_facet Heller, Simon
Raposo, João Filipe
Tofé, Santiago
Hanif, Wasim
Schroner, Zbynek
Down, Su
Blevins, Thomas
author_role author
author2 Raposo, João Filipe
Tofé, Santiago
Hanif, Wasim
Schroner, Zbynek
Down, Su
Blevins, Thomas
author2_role author
author
author
author
author
author
dc.contributor.none.fl_str_mv NOVA Medical School|Faculdade de Ciências Médicas (NMS|FCM)
RUN
dc.contributor.author.fl_str_mv Heller, Simon
Raposo, João Filipe
Tofé, Santiago
Hanif, Wasim
Schroner, Zbynek
Down, Su
Blevins, Thomas
dc.subject.por.fl_str_mv Internal Medicine
Endocrinology, Diabetes and Metabolism
SDG 3 - Good Health and Well-being
topic Internal Medicine
Endocrinology, Diabetes and Metabolism
SDG 3 - Good Health and Well-being
description Funding Information: Financial support for this article was provided by Viatris, Inc. Publisher Copyright: ©2023 by the American Diabetes Association.
publishDate 2023
dc.date.none.fl_str_mv 2023-07-18T22:16:23Z
2023-03
2023-03-01T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10362/155497
url http://hdl.handle.net/10362/155497
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 0891-8929
PURE: 66657222
https://doi.org/10.2337/cd22-0016
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv 9
application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799138146751873024

Registros relacionados